Apotex Pty Ltd v Sanofi-Aventis
| Jurisdiction | Australia Federal only |
| Neutral Citation | 2009-0929 FCA B,[2009] FCAFC 134,2008-0812 FCA A |
| Date | 2008 |
| Court | Full Federal Court (Australia) |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
10 cases
-
Merck Sharp and Dohme Corporation v Wyeth LLC (No 3)
...v Alphapharm Pty Limited [2002] HCA 59; 212 CLR 411 Allsop Inc v Bintang Ltd [1989] FCA 428; 15 IPR 686 Apotex Pty Ltd v Sanofi-Aventis [2009] FCAFC 134; 82 IPR 416 AstraZeneca AB v Apotex Pty Ltd [2014] FCAFC 99; 226 FCR 324 AstraZeneca AB v Apotex Pty Ltd [2015] HCA 30; 257 CLR 356 Austal......
- DSI Australia (Holdings) Pty Ltd v Garford Pty Ltd
- H Lundbeck A/S v Alphapharm Pty Ltd
- Vehicle Monitoring Systems Pty Ltd v Sarb Management Group Pty Ltd (trading as Database Consultants Australia) (No 2)
Request a trial to view additional results
4 firm's commentaries
-
Enabling Disclosure No Longer Required To Anticipate A Patent Claim
...bound by recent decisions of the Full Federal Court (e.g., Lundbeck v Alphapharm Pty Ltd [2009] FCAFC 70; and Apotex v Sanofi Aventis [2009] FCAFC 134), which were factually similar to the present case. His Honour held that the "disclosure of a compound by exact naming in the prior art is s......
-
What's prior disclosure of pharmaceutical compounds?
...Applying the Full Federal Court's decisions in H Lundbeck A/S v Alphapharm Pty Ltd [2009] FCAFC 60 and Apotex Pty Ltd v Sanofi-Aventis [2009] FCAFC 134, Justice Jessup rejected AMRI's arguments and held that exact naming of a compound in prior art is sufficient to constitute anticipation. F......
-
Death of the starting point approach under the Patents Act: AstraZeneca v Apotex
...known in the relevant prior art? The 'starting point' approach had previously been adopted by the Full Court in Apotex v Sanofi-Aventis [2009] FCAFC 134 ('Sanofi'), and has particular application in cases where the patent specification outlines a particular problem (and sets out to solve th......
-
Three strikes, you're out: Rosuvastatin generics in the clear
...finding on the construction of s7(3). This approach was previously adopted by an earlier Full Court in Apotex Pty Ltd v Sanofi-Aventis [2009] FCAFC 134 under the Patents Act 1952. It allowed information contained in the relevant patent specification, but which did not form part of the commo......